Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.
With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector.
Genentech enters a manufacturing and development agreement with Enable Injections to advance the latter’s patient-administered subcutaneous drug delivery system.
Haselmeier to provide assembly, labeling, and packaging services for its drug-device combination products following recent permission given to Germany-site.
The voluntary recall, originally initiated due to a product compliant in October 2018 for mislabeling, continues for anti-seizure drug, Levetiracetam injection in single-dose bags.
Increasing demand for reduced particle loads in pharmaceutical containers has driven Datwyler to build a CHF 100m plant making elastomer components for injectable drug delivery systems.
QuiO has raised $1.05m to develop its real-time adherence monitoring solution for injectable therapies – a device which could allow CROs to monitor injection events remotely.
Aptar Pharma has formed an alliance with Becton, Dickinson & Co to develop new self-injection devices that will tap into the strong growth in injectable drugs.
Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.
AMRI has paid $60m for two Aptuit facilities including an aseptic manufacturing site in Glasgow, UK which the firm says will boost its presence in Europe.
Unilife has signed a $40m long-term supply agreement with Hikma and says it is committed to becoming the world’s largest and most successful injectable drug delivery systems supplier.
West has begun production at its second manufacturing facility in China, driven by the growing market for pharma injectable components in the Asia pacific region.
Stason Pharmaceuticals’ subsidiary Standard Chem and Pharm will act as primary distributor for the Unitract 1ml safety syringe in China, Japan and Taiwan under a five-year new deal with US delivery device maker Unilife.
Abraxis Health has dedicated its manufacturing facility in Phoenix, Arizona, US which is the result of a $70m (€47m) investment to give the company the nanotech and biologics capacity needed for Abraxane production.
US contract manufacturer West Pharmaceutical Services has purchased French device firm Plastef Investissements’ drug delivery business, adding the eris safety syringe system to its offering.
Italian machining specialist Marchesini’s claims its new 150 carton per minute Unica monobloc packaging system offers syringe makers greater packaging flexibility, improved cleaning access and quicker change over.
Schott plans to add two giant glass melting tanks at its facility in Mainz, Germany, continuing the expansion of pharmaceutical tubing production capacity and creating 135 new jobs in the process.
Takeda Pharmaceutical has filed a lawsuit in an attempt to recoup $26.7m in damages, after it had to recall a product made by a contract manufacturing organisation (CMO).
Indian biotech company Biocon has started using pre-filled syringes
for the administration of granulocyte-colony stimulating factor
(GCSF) and erythropoietin.
With Asia increasingly becoming the destination of choice for
manufacturers and the domestic market blossoming, a major
components manufacturer has singled out its Singapore facility for
a multi-million dollar expansion.
German contract manufacturer Vetter Pharma-Fertigung has been
bestowed with a "facility of the year award" for the processes
employed at its new injectables plant.
France-based Rexam Pharma is gearing up to launch a safety add-on
device that fits on to prefilled syringes to help drugmakers comply
with recent legislations designed to prevent needlestick injuries.
Hospira, the hospital products company spun out of Abbott
Laboratories earlier this year, has acquired a manufacturing
facility that will help it grow its pharmaceutical injectable and
outsourcing business.
Needle-free injection systems are finally emerging as a serious
alternative to traditional syringes, despite first being introduced
in the middle of the last century.
